A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.
Clinical trial NCT02920242 · TERMINATED
Trial details
- NCT number
- NCT02920242
- Sponsor
- Sandoz
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-15
- Primary completion
- 2017-05-23
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.